Skip to main content
Premium Trial:

Request an Annual Quote

Guava Technologies Raises $7M in Venture Capital, Names New CEO

NEW YORK, Nov. 29 (GenomeWeb News) - Guava Technologies has raised $7 million in private-equity financing and has promoted Lawrence Bruder, the company's president and chief operating officer, to chief operating officer, the firm said today.

 

The venture capital was raised by existing investors Abingworth Life Science Investment, Granite Global Ventures, HLM Venture Partners, MDS Capital Corp., ProQuest Investments, and Skyline Ventures.

Bruder said the company expects to be cash-flow positive "within 12 months" and attributed the outlook on new products, sales to new customer bases "within the overall cell analysis market," and "penetration of foreign markets."

 

"The current financing will enable us to continue our growth initiative, bringing us more rapidly to self sufficiency," Bruder said in a statement.

The Scan

Cell Atlas of Human Lung Development Gives View of Developing Airway

Researchers have generated a cell atlas of human lung development, which they report in Cell.

Study Finds Costs of Genome Sequencing May Limit Utility in Routine Care

Researchers report in the European Journal of Human Genetics that genome sequencing for rare disease diagnoses currently has similar benefits as less expensive exome analysis.

Study Suggests Nursing Mother's Diet Can Impact Offspring's Gut Microbiome

A new Cell Host and Microbe paper finds that mice whose mothers were fed a low-fiber diet during nursing experience lasting microbiota dysbiosis and increased obesity.

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.